AbbVie circles Revolution Medicines in possible $20 billion-plus deal: WSJ, Bloomberg
New York, Jan 7, 2026, 16:14 (EST) AbbVie (ABBV.N) is in advanced talks to buy cancer-drug developer Revolution Medicines (RVMD.O), the Wall Street Journal reported on Wednesday, citing people familiar with the matter. Revolution shares jumped nearly 30% after the report, while AbbVie rose more than 5%. Reuters For AbbVie, a takeover would also sharpen its push to add new…